PRMT5 and neoplasm: We therefore engineered MCF7 cells to express a doxycycline (dox)-regulated PRMT5 silencing construct (Tet-ON-shPRMT5) in combination with constitutive expression of the luciferase gene enabling in vivo imaging of tumor growth (Figures 4A and 4B).